Abstract
In the field of developmental research, there is a pressing need to develop clinically sounded and empirically grounded tools for the assessment of personality development in adolescence. After a review of the relevant literature on adolescent personality disorders we present through empirical data and clinical material the IPOP-A, a semi-structured interview for adolescents ranging from 13 years old to 21 years old. The IPOP-A seems to be promising to gather information about processes that constitute the building blocks of adolescent personality organization.
Keywords: Adolescent personality disorders, assessment, borderline personality organization, IPOP-A, personality development, semi-structured interview
Adolescent Psychiatry
Title: Assessment of Adolescent Personality Disorders Through the Interview of Personality Organization Processes in Adolescence (IPOP-A): Clinical and Theoretical Implications
Volume: 2 Issue: 1
Author(s): Massimo Ammaniti, Andrea Fontana, Audrey Clarkin, John F. Clarkin, Giampaolo Nicolais and Otto F. Kernberg
Affiliation:
Keywords: Adolescent personality disorders, assessment, borderline personality organization, IPOP-A, personality development, semi-structured interview
Abstract: In the field of developmental research, there is a pressing need to develop clinically sounded and empirically grounded tools for the assessment of personality development in adolescence. After a review of the relevant literature on adolescent personality disorders we present through empirical data and clinical material the IPOP-A, a semi-structured interview for adolescents ranging from 13 years old to 21 years old. The IPOP-A seems to be promising to gather information about processes that constitute the building blocks of adolescent personality organization.
Export Options
About this article
Cite this article as:
Ammaniti Massimo, Fontana Andrea, Clarkin Audrey, F. Clarkin John, Nicolais Giampaolo and F. Kernberg Otto, Assessment of Adolescent Personality Disorders Through the Interview of Personality Organization Processes in Adolescence (IPOP-A): Clinical and Theoretical Implications, Adolescent Psychiatry 2012; 2 (1) . https://dx.doi.org/10.2174/2210676611202010036
DOI https://dx.doi.org/10.2174/2210676611202010036 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Endothelial Nitric Oxide in Cerebrovascular Regulation
Current Pharmaceutical Biotechnology Anti-Chlamydophila pneumoniae Antibodies as Associated Factor for Carotid Atherosclerosis in Patients with AIDS
Current HIV Research Glibenclamide Action on Myocardial Function and Arrhythmia Incidence in the Healthy and Diabetic Heart
Cardiovascular & Hematological Agents in Medicinal Chemistry Peptides, Proteins and Peptide/Protein-Polymer Conjugates as Drug Delivery System
Protein & Peptide Letters New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012
Current Topics in Medicinal Chemistry Intrinsic Disorder-based Protein Interactions and their Modulators
Current Pharmaceutical Design Metabolic Syndrome and Cognitive Decline
Current Alzheimer Research State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies
Current Medicinal Chemistry Caffeic Acid Phenethyl Ester Effects: In Silico Study of its Osteoimmunological Mechanisms
Letters in Drug Design & Discovery Transdermal Drug Delivery Systems and their Potential in Alzheimer’s Disease Management
CNS & Neurological Disorders - Drug Targets Phosphodiesterase 10 Inhibitors: New Disease Modifying Drugs for Parkinson’s Disease?
Current Medicinal Chemistry Potential Protective Effects of Cannabidiol on Neuroanatomical Alterations in Cannabis Users and Psychosis: A Critical Review
Current Pharmaceutical Design Proteomic analysis of a <i>hom</i>-disrupted, cephamycin C overproducing <i>Streptomyces clavuligerus</i>
Protein & Peptide Letters Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
Current Alzheimer Research Recent Advances in the Design and Synthesis of Prednisolone and Methylprednisolone Conjugates
Current Pharmaceutical Design Editorial [Hot Topic:Are the Pleiotropic Effects of Drugs Used for the Prevention of Cardiovascular Disease Clinically Relevant?(Executive Editors: M. Elisaf and E.N. Liberopoulos)]
Current Pharmaceutical Design Editorial (Thematic Issue: Emerging Targets for Stimulant Use Disorders: Where To Invest In An Era Of Constrained Resources?)
CNS & Neurological Disorders - Drug Targets Drug Conjugated Nanomedicine as Prodrug Carrier
Nanoscience & Nanotechnology-Asia An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants
Current Neuropharmacology Palmitoylethanolamide Relieves Pain and Preserves Pancreatic Islet Cells in a Murine Model of Diabetes
CNS & Neurological Disorders - Drug Targets